> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Stereotaxis Sales Rise 20% With New Robot Revenue, But Catheter Shortages Limit Procedures
- URL: https://www.bullished.co/stereotaxis-sales-rise-20-with-new-robot-revenue-but-catheter-shortages-limit-procedures-6a65c95f/
- Published: 2026-11-10T22:06:20.000Z
- Updated: 2026-11-10T22:06:20.000Z
- Description: The company closed $12 million in financing as Robocath costs widened its adjusted loss.
- Author: Matteo Parrino
- Tags: SEC Filings, STXS, Industry: Healthcare

Stereotaxis, which sells surgical robots and disposable catheters, grew third-quarter sales [20% to $8.9 million](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/form8-k.htm?ref=bullished.co), with new robot-system revenue helping offset catheter shortages that limited procedures. Its Tuesday SEC filing also detailed $12 million in financing that closed Monday, replenishing a quarter-end cash balance of $4.0 million.

## New Systems, Unfilled Catheter Orders

Sales were $7.5 million a year earlier and $7.7 million in the second quarter; the latest result was up 16% from that second-quarter level. System revenue rose 60% to $3.0 million from $1.9 million, according to the company's [earnings release](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/ex99-1.htm?ref=bullished.co).

Stereotaxis attributed the system increase to recognizing part of the revenue from its first U.S. GenesisX shipment and first Genesis shipment in China, plus a full quarter of Synchrony operating-room system sales. Disposables, service and accessories brought in $5.9 million, up 6% year over year but down 4% from the second quarter.

The company said catheter supply shortages constrained procedures and left approximately $1.9 million of disposable orders unfilled entering the fourth quarter. Gross margin—the share of sales left after direct costs—was 45%, with recurring products and services at 59% and systems at 15%. Stereotaxis attributed margin pressure to spreading fixed overhead over low production volumes.

For the first nine months, sales were $22.9 million, below $23.7 million a year earlier.

## Robocath Adds Costs And Capabilities

Stereotaxis completed its Robocath purchase during the quarter and announced a collaboration with Canon. On November 1, it presented [initial human results](https://finance.yahoo.com/markets/stocks/articles/top-robotics-stocks-strong-potential-153300390.html?.tsrc=rss&ref=bullished.co) from coronary procedures using Robocath's next-generation robotic system at TCT.

The company attributed its wider adjusted net loss—$5.2 million versus $2.4 million a year earlier—mainly to Robocath transaction and operating costs. Reported net loss was $6.5 million in both periods. Adjusted operating expenses rose to $9.1 million from $6.6 million; total operating expenses were $10.4 million, including $1.3 million in non-cash charges.

Cash outflow totaled $6.5 million: $3.9 million involved Robocath acquisition payments and $2.6 million the core Stereotaxis business.

Chairman and CEO David Fischel described a strategy of moving beyond systems with lengthy sales and construction cycles while building disposable products that "enhance the value of our robots and provide a [robust recurring revenue](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/ex99-1.htm?ref=bullished.co) opportunity."

## Cash Today, Potential Shares Later

The financing provided [$12 million](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/form8-k.htm?ref=bullished.co) in gross proceeds, with another $12 million available at the company's option subject to conditions and regulatory milestones. Investors included entities affiliated with board members.

The initial debt can convert into common shares at $1.21 each, a 30% premium to the stock's preceding 10-day volume-weighted average price. The notes charge 10% annual interest and mature in three years; interest generally accumulates into principal until maturity. Conversion would increase the share count.

The company's [financing announcement](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/ex99-2.htm?ref=bullished.co) put pro forma cash at $16 million and total availability, including the conditional draw, at $28 million. Stereotaxis intends to fund working capital, product commercialization and research and development.

Management expects adjusted quarterly operating expenses, excluding non-cash and one-time items, of about $8 million. It sees revenue growth and stable expenses providing a route to positive cash flow within the next year.

Stereotaxis identified initial commercial GenesisX installations and resolving MAGiC catheter supply constraints as the near-term milestones behind its expectations for growth.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — Stereotaxis, Inc. (STXS)](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/form8-k.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit ex99-1.htm — Stereotaxis, Inc. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/ex99-1.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit ex99-2.htm — Stereotaxis, Inc. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001289340/000149315226050957/ex99-2.htm?ref=bullished.co) — SEC EDGAR
- [Top Robotics Stocks With Strong Potential for Long-Term Growth](https://finance.yahoo.com/markets/stocks/articles/top-robotics-stocks-strong-potential-153300390.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Stereotaxis Reports 2026 Third Quarter Financial Results &](https://www.globenewswire.com/news-release/2026/11/10/3400189/0/en/stereotaxis-reports-2026-third-quarter-financial-results-business-updates.html?ref=bullished.co) — globenewswire.com
- [Stereotaxis Announces Convertible Note Financing of Up To](https://www.globenewswire.com/news-release/2026/11/10/3400180/21634/en/stereotaxis-announces-convertible-note-financing-of-up-to-24-million.html?ref=bullished.co) — globenewswire.com